Defence Therapeutics Inc.
DTC
शेयरों में रैंक
#29460
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
शेयर मूल्य
$0.25964327
अंतिम समन्वयन: 2026-10-21
मार्केट कैप
$19.68M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-55.64%
देश
CA
व्यापार Defence Therapeutics Inc. (DTC)
श्रेणी
Healthcare
Defence Therapeutics Inc. (DTC) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.27 (2026-10-01 को)
दिन का सबसे निम्न समापन मूल्य: $2.50 (2021-05-01 को)
दिन का सबसे निम्न समापन मूल्य: $2.50 (2021-05-01 को)
Defence Therapeutics Inc. के स्टॉक मूल्य का इतिहास 2021 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
| वर्ष | प्रदर्शन |
|---|---|
| 2026 (TTM) | -27.66% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
| कंपनी | स्टॉक मूल्य | परिवर्तन 1व% | देश |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $765.49 | 8.80% |
CH
|
